BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2937302)

  • 1. Variability of thymidylate synthase activity in whole blood cultures treated with FUdR.
    Sklower SL; Jenkins EC; Anderson ML; Chan CB; Brown WT
    Am J Med Genet; 1986; 23(1-2):483-90. PubMed ID: 2937302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragile X expression increased by low cell-culture density.
    Krawczun MS; Lele KP; Jenkins EC; Brown WT
    Am J Med Genet; 1986; 23(1-2):467-73. PubMed ID: 2937301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fragile (X) expression induced by FUdR is transient and inversely related to levels of thymidylate synthase activity.
    CantĂș ES; Nussbaum RL; Airhart SD; Ledbetter DH
    Am J Hum Genet; 1985 Sep; 37(5):947-55. PubMed ID: 2931977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress toward an internal control system for fragile-X induction by 5-fluorodeoxyuridine in whole-blood cultures.
    Jenkins EC; Duncan CJ; Sanz MM; Genovese M; Gu H; Schwartz-Richstein C; Lele KP; Salandi ML; Krawczun MS
    Pathobiology; 1990; 58(4):236-40. PubMed ID: 2147548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fragile X(q27) form of X-linked mental retardation: FUdR as an inducing agent for fra(X)(q27) expression in lymphocytes, fibroblasts, and amniocytes.
    Brookwell R; Daniel A; Turner G; Fishburn J
    Am J Med Genet; 1982 Oct; 13(2):139-48. PubMed ID: 6215863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of tri- or multiradial configurations in fragile X identification.
    Jenkins EC; Duncan CJ; Krawczun MS; Berns LM; Sanz MM; Brown WT
    Am J Med Genet; 1986; 23(1-2):531-5. PubMed ID: 2937304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FUdR induction of the X chromosome fragile site: evidence for the mechanism of folic acid and thymidine inhibition.
    Glover TW
    Am J Hum Genet; 1981 Mar; 33(2):234-42. PubMed ID: 6452060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of caffeine on fragile X expression.
    Abruzzo MA; Pettay D; Mayer M; Jacobs PA
    Hum Genet; 1986 May; 73(1):20-2. PubMed ID: 2940164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidylate synthetase inhibitors and fragile site expression in lymphocytes.
    Jacky PB; Sutherland GR
    Am J Hum Genet; 1983 Nov; 35(6):1276-83. PubMed ID: 6228136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caffeine enhances fragile (X) expression in somatic cell hybrids.
    Ledbetter DH; Airhart SD; Nussbaum RL
    Am J Med Genet; 1986; 23(1-2):445-55. PubMed ID: 2937299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combined effects of FUdR addition and methionine depletion on the X-chromosome fragile site.
    Glover TW; Howard-Peebles PN
    Am J Hum Genet; 1983 Jan; 35(1):117-22. PubMed ID: 6218753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragile X expression in short-term whole blood cultures is affected by cell density.
    Krawczun MS; Jenkins EC; Brown WT; Silverman WP
    Am J Med Genet; 1988; 30(1-2):435-42. PubMed ID: 2972206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent experience in prenatal fra(X) detection.
    Jenkins EC; Brown WT; Krawczun MS; Duncan CJ; Lele KP; Cantu ES; Schonberg S; Golbus MS; Sekhon GS; Stark S
    Am J Med Genet; 1988; 30(1-2):329-36. PubMed ID: 2972205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced sensitivity of lymphoblastoid cells from individuals carrying the mutation for the fragile X syndrome to the clastogenic effects of FUdR.
    Duncan AM
    Mutat Res; 1986 Mar; 173(3):201-5. PubMed ID: 2936953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialyzed fetal bovine serum increases cytogenetic fragile X expression.
    Jenkins EC; Duncan CJ; Gu H; Genovese M; Krawczun MS
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):155-60. PubMed ID: 1534967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of the common fragile site at Xq27.2 under conditions of thymidylate stress: implications for cytogenetic diagnosis of the fragile-X syndrome.
    Ramos FJ; Emanuel BS; Spinner NB
    Am J Med Genet; 1992 Apr; 42(6):835-8. PubMed ID: 1532475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of diploidy, polyploidy, and endoreduplication in fra(X) positive and negative lymphocytes, amniocytes, and chorionic villi.
    Jenkins EC; Sanz MM; Ray JH; Stark-Houck SL; Brown WT
    Am J Med Genet; 1991; 38(2-3):434-6. PubMed ID: 1826811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prenatal detection of the fragile X chromosome: review of recent experience.
    Jenkins EC; Brown WT; Wilson MG; Lin MS; Alfi OS; Wassman ER; Brooks J; Duncan CJ; Masia A; Krawczun MS
    Am J Med Genet; 1986; 23(1-2):297-311. PubMed ID: 2937295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved prenatal detection of fra(X)(q27.3): methods for prevention of false negatives in chorionic villus and amniotic fluid cell cultures.
    Jenkins EC; Krawczun MS; Stark-Houck SL; Duncan CJ; Kunaporn S; Gu H; Schwartz-Richstein C; Howard-Peebles PN; Gross A; Sherman SL
    Am J Med Genet; 1991; 38(2-3):447-52. PubMed ID: 1826813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic guidelines for fragile X studies tested in routine practice.
    Dewald GW; Buckley DD; Spurbeck JL; Jalal SM
    Am J Med Genet; 1992 Dec; 44(6):816-21. PubMed ID: 1481854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.